These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. Rogers A, Saleh G, Hannon RA, Greenfield D, Eastell R. J Clin Endocrinol Metab; 2002 Oct; 87(10):4470-5. PubMed ID: 12364420 [Abstract] [Full Text] [Related]
4. Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status. Fahrleitner-Pammer A, Dobnig H, Piswanger-Soelkner C, Bonelli C, Dimai HP, Leb G, Obermayer-Pietsch B. Wien Klin Wochenschr; 2003 May 15; 115(9):291-7. PubMed ID: 12793029 [Abstract] [Full Text] [Related]
7. [The relationships between changes of serum osteoprotegerin, nuclear factor-kappa B ligand receptor activator, and age, menopause, bone biochemical markers and bone mineral densities in women aged 20 - 75]. Liu JM, Zhao HY, Ning G, Zhao YJ, Chen Y, Zhang LZ, Xu MY, Chen JL. Zhonghua Nei Ke Za Zhi; 2004 Jun 15; 43(6):447-50. PubMed ID: 15312444 [Abstract] [Full Text] [Related]
8. Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. Morabito N, Gaudio A, Lasco A, Atteritano M, Pizzoleo MA, Cincotta M, La Rosa M, Guarino R, Meo A, Frisina N. J Bone Miner Res; 2004 May 15; 19(5):722-7. PubMed ID: 15068494 [Abstract] [Full Text] [Related]
9. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A, Ikeda K, Higashio K, Yamada Y. J Bone Miner Res; 1999 Apr 15; 14(4):518-27. PubMed ID: 10234572 [Abstract] [Full Text] [Related]
12. Correlates of osteoprotegerin levels in women and men. Khosla S, Arrighi HM, Melton LJ, Atkinson EJ, O'Fallon WM, Dunstan C, Riggs BL. Osteoporos Int; 2002 May 15; 13(5):394-9. PubMed ID: 12086350 [Abstract] [Full Text] [Related]
13. Relationships between the changes of serum levels of OPG and RANKL with age, menopause, bone biochemical markers and bone mineral density in Chinese women aged 20-75. Liu JM, Zhao HY, Ning G, Zhao YJ, Chen Y, Zhang Zh, Sun LH, Xu MY, Chen JL. Calcif Tissue Int; 2005 Jan 15; 76(1):1-6. PubMed ID: 15455183 [Abstract] [Full Text] [Related]
18. The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients: a pilot study. Wu WT, Lee RP, Wang CH, Fang TC, Lin NT, Chen IH, Hsu BG. J Womens Health (Larchmt); 2010 Apr 15; 19(4):785-90. PubMed ID: 20210559 [Abstract] [Full Text] [Related]
19. Osteoprotegerin and bone mass in squamous cell head and neck cancer patients. Valero C, Olmos JM, Rivera F, Hernández JL, Vega ME, Macías JG. Calcif Tissue Int; 2006 Jun 15; 78(6):343-7. PubMed ID: 16830204 [Abstract] [Full Text] [Related]
20. [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women]. Cheng Q, Zhu HM, Miao YX, Zhu XY, Chen XP, Zhang XM. Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):274-7. PubMed ID: 15059506 [Abstract] [Full Text] [Related] Page: [Next] [New Search]